Molecular Formula | C27H24N2O9
|
Molar Mass | 520.49 |
Density | 1.467±0.06 g/cm3(Predicted) |
Melting Point | 116-120°C |
Boling Point | 706.4±60.0 °C(Predicted) |
Solubility | DMSO: ≥ 35 mg/mL |
Appearance | White to off-white solid |
Color | light yellow to yellow-green |
pKa | 13.32±0.29(Predicted) |
Storage Condition | 2-8°C |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months |
In vitro study | JZL184 is a useful tool for studying the role of endogenous 2-AG signaling. JZL184 time-dependently inhibited MAGL with a selectivity of more than 300 times that of FAAH. JZL184 does not interact with CB1 or CB2 receptors and does not inhibit the biosynthetic enzymes diacylglycerol lipase-α and diacylglycerol lipase-β of 2-AG, or arachidonic acid mobilization enzyme cytoplasmic phospholipase A2 group IVA. |
In vivo study | JZL184 rapidly and consistently inhibits mouse brain 2-AG hydrolase activity, resulting in an 8-fold increase in endogenous 2-AG levels that is maintained for at least 8 hours. Jzl184treated mice showed a wide range of cb1-dependent behavioral effects, including analgesia, hypokinematics and hypothermia, that is, a broad role for 2-AG-mediated endocannabinoid signaling throughout the mammalian nervous system is indicated. |